Condition: Moderately to Severely Active Crohns Disease · Sponsor: Hoffmann-La Roche
This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance therapy with Afimkibart (also known as RO7790121) in participants with moderately to severely active Crohn's disease (CD).
This description comes directly from the study's public registry record.
Reference Study ID Number: GA45331 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. and Canada) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| Digestive Health Specialists of the Southeast (Gastroenterology Associates of Dothan) - Dothan | Dothan, Alabama, United States | Recruiting |
| Mayo Clinic Hospital | Phoenix, Arizona, United States | Recruiting |
| Arizona Digestive Health, P.C (ADH) | Sun City, Arizona, United States | Recruiting |
| University of Arizona-CATS Research Center | Tucson, Arizona, United States | Recruiting |
| Valley View Internal Medicine | Garden Grove, California, United States | Recruiting |
| 310 Clinical Research | Inglewood, California, United States | Recruiting |
| UCSD Medical Center | La Jolla, California, United States | Recruiting |
| Gastro Care Associates | Lancaster, California, United States | Recruiting |
| Om Research LLC | Lancaster, California, United States | Recruiting |
| United Gastroenterologists | Los Alamitos, California, United States | Recruiting |
| Acclaim Clinical Research, Inc. | San Diego, California, United States | Recruiting |
| Kaiser Permanente | San Francisco, California, United States | Recruiting |
+ 360 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06819878